Gurnee, Illinois
United States
46
2025-01-16
The entities that hold a legal rights for patent applications filed by inventor Ding Hong:
Hong Ding from Gurnee, US has applied for patents for these inventions. The list has both pending applications and granted patents:
APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#2 | 2024-02-08APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#3 | 2023-05-11Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
#4 | 2022-10-06APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#5 | 2021-07-22APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#6 | 2020-07-23APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#7 | 2019-04-25APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#8 | 2018-09-06APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#9 | 2017-06-08APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#10 | 2016-01-14Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#11 | 2015-11-19APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#12 | 2015-07-02Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
#13 | 2014-07-03Apoptosis promoters
#14 | 2014-04-24APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#15 | 2014-04-17Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#16 | 2014-04-03Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
#17 | 2014-03-06Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
#18 | 2014-02-27BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#19 | 2014-02-27Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#20 | 2013-11-07BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#21 | 2013-07-25Apoptosis promoters
#22 | 2012-07-26APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#23 | 2011-10-271-oxyalkyl-2-carboxy-7-nonsubstituted indole derivatives
#24 | 2011-10-20Apoptosis promoters
#25 | 2011-06-16Apoptosis promoters
#26 | 2010-12-02Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
#27 | 2010-11-25Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
#28 | 2010-11-25BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#29 | 2010-09-30Apoptosis promoters
#30 | 2010-09-23Apoptosis promoters
#31 | 2010-09-16Biaryl carboxylic acid apoptosis promoters
#32 | 2010-07-22Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
#33 | 2010-06-24APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#34 | 2010-06-17Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#35 | 2010-01-28Apoptosis promoters
#36 | 2009-05-28N-acylsulfonamide apoptosis promoters
#37 | 2009-05-141-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivatives
#38 | 2009-03-17N-acylsulfonamide apoptosis promoters
#39 | 2008-11-20Apoptosis promoters
#40 | 2007-06-14Apoptosis promoters
#41 | 2007-03-29Apoptosis promoters
#42 | 2007-02-01Apoptosis promoters
#43 | 2007-01-18Apoptosis promoters
#44 | 2006-11-16Apoptosis promoters
#45 | 2006-06-15Apoptosis promoters
#46 | 2005-07-21N-acylsulfonamide apoptosis promoters
356012 ⎘